bullish

JD Health (6618.HK) - It's Time to Reassess the Business Prospects and Valuation

The essence of JD Health's business is “pharmaceutical e-commerce” rather than “a comprehensive online healthcare platform”. Without second growth point with certainty, high valuation is unreasonable.
320 Views09 Mar 2023 08:55
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Analytics & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
x